Home Search Abstracts Browse Sessions Program Committee E-mail Abstract Author View Session


Session 23 Oral Abstracts
HIV/HCV Co-Infection
Tuesday, 4 - 6:15 pm
Presentation Time: 5:00 pm
Room 3000


114
Frequency of Functional HCV-specific CD8+ Cells Depends on Total CD4+ Counts in HIV-1/HCV Co-infection: Implications for Immune Reconstitution
A Y Kim*1, K Ouchi1, R Draenert1, M M Addo1, M Lucas2, M A Boczanowski1, A G Wurcel1,3, B McGovern3,4, D Casson5, RT Chung5, P Klenerman2, B D Walker1, and G M Lauer1
1Partners AIDS Res. Ctr., Massachusetts Gen. Hosp., Charlestown, USA; 2Oxford Univ., UK; 3Lemuel Shattuck Hosp., Jamaica Plain, MA, USA; 4Tufts Med. Sch., Boston, MA, USA; and 5Massachusetts Gen. Hosp., Boston, USA

Background:  Virus-specific CD8+ cells play an important role in control of both SIV in macaques and HCV in chimpanzees, but no animal model has adequately studied HIV/HCV co-infection.  We performed cross-sectional analysis in a large cohort of co-infected humans to determine the effects of HIV on HCV-specific functional immunity.

Methods:  We studied 61 HIV+/HCV+ co-infected and 22 HIV-/HCV+ mono-infected individuals. No subject had ever received interferon therapy for chronic HCV.  To determine comprehensively the HCV-specific CD8+ response in peripheral blood, we applied established approaches using a matrix IFN-g ELISpot with 494 peptides that span the entire genome, verifying novel responses by generation of specific T-cell lines and testing by intracellular cytokine staining. HIV-1 responses were determined using analogous comprehensive approaches. Tetramers were then used for further analysis.

Results:  We detected ex vivo HCV-specific CD8 cells in 29/61 (47.5%) of co-infected and in 9/22 (40.9%) of mono-infected individuals. Single tetramer responses were as high as 3.6% of circulating CD8 cells. When analyzing persons with chronic HCV viremia (46 HIV+ versus 22 HIV- subjects), there were no differences in breadth (p = 0.58) or magnitude (p = 0.53) between the mono- and co-infected groups.  However, a significant relationship emerged between peripheral CD4 cell counts and breadth (i>R = 0.44, p <0.001) and magnitude of HCV-specific responses (R = 0.40, p = 0.002).  This relationship was significant whether when analysis was restricted to HAART status and to those with genotype 1.  In contrast, no such correlation existed for HIV-1 responses.  Longitudinal data on subjects followed on HAART and phenotypic data will also be presented.

Conclusions:  Surprisingly high frequencies of HCV-specific CD8 T cells are detected in HIV infection and did not differ from those without HIV.  Only when CD4 cells are depleted due to progressive HIV is the HCV--specific CD8+ response significantly diminished. Conversely, these results suggest that functional immunity specific for HCV may augment on HAART, in contrast to HIV-1 responses which decline.  These results shed insight into the relationship between CD4+ and CD8+ cells in a human viral infection.  Moreover, these data provide rationale for further detailed longitudinal studies on HAART, to study prospectively immune reconstitution in co-infected subjects.

Keywords: Hepatitis C; CD8+ T lymphocytes; Immunology